Cargando…
Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign
BACKGROUND: In April 2014, a national school-based human papillomavirus (HPV) vaccination program was rolled out in South Africa, targeting Grade 4 girls aged ≥9 years. A bivalent HPV vaccine with a 2-dose (6 months apart) schedule was used. At the request of the National Department of Health (NDoH)...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Global Health: Science and Practice
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172125/ https://www.ncbi.nlm.nih.gov/pubmed/30143561 http://dx.doi.org/10.9745/GHSP-D-18-00090 |
_version_ | 1783360881277534208 |
---|---|
author | Delany-Moretlwe, Sinead Kelley, Karen F. James, Shamagonam Scorgie, Fiona Subedar, Hasina Dlamini, Nonhlanhla R Pillay, Yogan Naidoo, Nicolette Chikandiwa, Admire Rees, Helen |
author_facet | Delany-Moretlwe, Sinead Kelley, Karen F. James, Shamagonam Scorgie, Fiona Subedar, Hasina Dlamini, Nonhlanhla R Pillay, Yogan Naidoo, Nicolette Chikandiwa, Admire Rees, Helen |
author_sort | Delany-Moretlwe, Sinead |
collection | PubMed |
description | BACKGROUND: In April 2014, a national school-based human papillomavirus (HPV) vaccination program was rolled out in South Africa, targeting Grade 4 girls aged ≥9 years. A bivalent HPV vaccine with a 2-dose (6 months apart) schedule was used. At the request of the National Department of Health (NDoH), we conducted an external assessment of the first-dose phase of the vaccination program to evaluate program coverage and vaccine safety and identify factors that influenced implementation. METHODS: We based our cross-sectional and mixed-methods approach on a process evaluation framework, which included a review of key planning and implementation documents and monitoring data; observation at vaccination sites; key informant interviews (N=34); and an assessment of media coverage and content related to the campaign. Findings: There was overall success in key measures of coverage and safety. Over 350,000 Grade 4 girls were vaccinated in more than 16,000 public schools across South Africa, which translated to 94.6% of schools reached and 86.6% of age-eligible learners vaccinated. No major adverse events following immunization were detected. We attributed the campaign's successes to careful planning and coordination and strong leadership from the NDoH. The primary challenges we identified were related to obtaining informed consent, vulnerabilities in cold chain capacity, and onsite management of minor adverse events. While campaign planners anticipated and prepared for some negative media coverage, they did not expect the use of social media for spreading misinformation about HPV vaccination. CONCLUSIONS: The first phase of the national school-based HPV vaccination campaign was successfully implemented at scale in this setting. Future implementation will require improvement in the storage and monitoring of vaccine doses, better communication of role expectations to all stakeholders, and streamlined consent processes to ensure program sustainability. |
format | Online Article Text |
id | pubmed-6172125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Global Health: Science and Practice |
record_format | MEDLINE/PubMed |
spelling | pubmed-61721252018-10-21 Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign Delany-Moretlwe, Sinead Kelley, Karen F. James, Shamagonam Scorgie, Fiona Subedar, Hasina Dlamini, Nonhlanhla R Pillay, Yogan Naidoo, Nicolette Chikandiwa, Admire Rees, Helen Glob Health Sci Pract Original Articles BACKGROUND: In April 2014, a national school-based human papillomavirus (HPV) vaccination program was rolled out in South Africa, targeting Grade 4 girls aged ≥9 years. A bivalent HPV vaccine with a 2-dose (6 months apart) schedule was used. At the request of the National Department of Health (NDoH), we conducted an external assessment of the first-dose phase of the vaccination program to evaluate program coverage and vaccine safety and identify factors that influenced implementation. METHODS: We based our cross-sectional and mixed-methods approach on a process evaluation framework, which included a review of key planning and implementation documents and monitoring data; observation at vaccination sites; key informant interviews (N=34); and an assessment of media coverage and content related to the campaign. Findings: There was overall success in key measures of coverage and safety. Over 350,000 Grade 4 girls were vaccinated in more than 16,000 public schools across South Africa, which translated to 94.6% of schools reached and 86.6% of age-eligible learners vaccinated. No major adverse events following immunization were detected. We attributed the campaign's successes to careful planning and coordination and strong leadership from the NDoH. The primary challenges we identified were related to obtaining informed consent, vulnerabilities in cold chain capacity, and onsite management of minor adverse events. While campaign planners anticipated and prepared for some negative media coverage, they did not expect the use of social media for spreading misinformation about HPV vaccination. CONCLUSIONS: The first phase of the national school-based HPV vaccination campaign was successfully implemented at scale in this setting. Future implementation will require improvement in the storage and monitoring of vaccine doses, better communication of role expectations to all stakeholders, and streamlined consent processes to ensure program sustainability. Global Health: Science and Practice 2018-10-03 /pmc/articles/PMC6172125/ /pubmed/30143561 http://dx.doi.org/10.9745/GHSP-D-18-00090 Text en © Delany-Moretlwe et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-18-00090 |
spellingShingle | Original Articles Delany-Moretlwe, Sinead Kelley, Karen F. James, Shamagonam Scorgie, Fiona Subedar, Hasina Dlamini, Nonhlanhla R Pillay, Yogan Naidoo, Nicolette Chikandiwa, Admire Rees, Helen Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign |
title | Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign |
title_full | Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign |
title_fullStr | Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign |
title_full_unstemmed | Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign |
title_short | Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign |
title_sort | human papillomavirus vaccine introduction in south africa: implementation lessons from an evaluation of the national school-based vaccination campaign |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172125/ https://www.ncbi.nlm.nih.gov/pubmed/30143561 http://dx.doi.org/10.9745/GHSP-D-18-00090 |
work_keys_str_mv | AT delanymoretlwesinead humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign AT kelleykarenf humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign AT jamesshamagonam humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign AT scorgiefiona humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign AT subedarhasina humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign AT dlamininonhlanhlar humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign AT pillayyogan humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign AT naidoonicolette humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign AT chikandiwaadmire humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign AT reeshelen humanpapillomavirusvaccineintroductioninsouthafricaimplementationlessonsfromanevaluationofthenationalschoolbasedvaccinationcampaign |